Episode 24: A Between the Biotech Waves conversation with John Hoffman, managing director & head of healthcare equity capital markets at Credit Suisse
Between the Biotech Waves
00:00
Introduction
John Hoffman is managing director and head of healthcare equity capital markets accredit Suisse. In mid 2022, John joined the podcast to discuss the market outlook for 22 and many visit predictions were spot on. I'm welcoming him back to review 2022, Lessons Learned, and Crystal Ballgaze into 2023. What are we seeing overall in the capital markets? Is M&A now on the horizon? And what should pre IPO companies be thinking about?
Play episode from 00:00
Transcript
